Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2084761000168116 | ropivacaine hydrochloride 100 mg / 20 mL injection, 5 x 20 mL ampoules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2084771000168110 | ropivacaine hydrochloride 100 mg/20 mL injection, 5 x 20 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ropivacaine hydrochloride 100 mg/20 mL injection, 5 x 20 mL ampoules | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 100 mg/20 mL injection, 5 x 20 mL ampoules | has MPUU | ropivacaine hydrochloride 100 mg/20 mL injection, ampoule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ropivacaine 0.5% (Actavis) 100 mg/20 mL injection, 5 x 20 mL ampoules | Is a | True | ropivacaine hydrochloride 100 mg/20 mL injection, 5 x 20 mL ampoules | Inferred relationship | Some | |
| Naropin 0.5% 100 mg/20 mL injection, 5 x 20 mL ampoules | Is a | True | ropivacaine hydrochloride 100 mg/20 mL injection, 5 x 20 mL ampoules | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Medicinal product pack reference set
FHIR